RECKITT BENCKIS/S to Post FY2019 Earnings of $0.86 Per Share, Jefferies Financial Group Forecasts (RBGLY)

RECKITT BENCKIS/S (OTCMKTS:RBGLY) – Equities researchers at Jefferies Financial Group lowered their FY2019 EPS estimates for RECKITT BENCKIS/S in a research note issued to investors on Tuesday, May 7th. Jefferies Financial Group analyst M. Deboo now expects that the company will earn $0.86 per share for the year, down from their previous estimate of $0.87. Jefferies Financial Group has a “Underperform” rating on the stock. Jefferies Financial Group also issued estimates for RECKITT BENCKIS/S’s FY2020 earnings at $0.90 EPS, FY2021 earnings at $0.94 EPS and FY2022 earnings at $0.98 EPS.

Separately, Zacks Investment Research upgraded shares of RECKITT BENCKIS/S from a “hold” rating to a “buy” rating and set a $19.00 price objective on the stock in a research note on Wednesday, March 27th.

OTCMKTS RBGLY opened at $16.09 on Thursday. RECKITT BENCKIS/S has a 12 month low of $14.64 and a 12 month high of $18.67. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.48 and a current ratio of 0.65. The firm has a market cap of $56.27 billion, a price-to-earnings ratio of 17.88, a P/E/G ratio of 4.96 and a beta of 0.87.


Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Featured Story: Do Tariffs Work?

Earnings History and Estimates for RECKITT BENCKIS/S (OTCMKTS:RBGLY)

Receive News & Ratings for RECKITT BENCKIS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RECKITT BENCKIS/S and related companies with's FREE daily email newsletter.